Banjak Marc 4

What Happened
Marc Banjak, Chief Legal Officer of iBio (IBIO), made two purchases of company stock on 2026-03-26, acquiring a total of 13,934 shares for a combined cash outlay of approximately $23,055. The trades were recorded as purchases (transaction code P): 12,500 shares at $1.64 (reported value $20,531) and 1,434 shares at $1.76 (reported value $2,524). These were purchases (buys), which investors often view as a more informative signal than routine sales, though the filing does not state the insider’s motivation.

Key Details

• Transaction dates: 2026-03-26 (both trades)
• Prices and amounts: 12,500 shares @ $1.64 (reported $20,531); 1,434 shares @ $1.76 (reported $2,524)
• Total purchased: 13,934 shares for about $23,055
• Transaction type: Open market or private purchase (code P) as reported on the Form 4
• Shares owned after transaction: Not specified in the provided filing excerpt
• Filing timeliness: Form 4 filed 2026-03-27 for transactions on 2026-03-26 — appears timely; no 10b5-1 plan or other footnotes disclosed in the data provided

Context
Insider purchases are commonly watched by retail investors as a potential positive signal, but they do not guarantee future performance. This filing shows modest-dollar insider buying (~$23k total), which is relatively small in dollar terms; interpret accordingly alongside other factors (company fundamentals, recent news, and overall insider activity).